Dr. Carlos Dujovne MD

Council Member Biography

Carlos Dujovne, MD, is an Affiliate Professor of Medicine, CV Division, Director, Clinical Cardiovascular-Metabolic Risk Treatment, and Prevention Programs at Oregon Health and Science University, Portland since July 2008. He is Board Certified/qualified in Internal Medicine, Gastroenterology, Cardiology, Clinical Pharmacology, Bariatrics and Clinical Lipidology. Previously, Dr. Dujovne was a Professor of Medicine & Pharmacology, Director, Clinical Pharmacology's Lipid Arteriosclerosis Prevention &Treatment Clinic, Department of Medicine and Pharmacology at University of Kansas, KS Foundation for Clinical Pharmacology and Therapeutics from 1970 to 1998. He conducted clinical R&D trials for all lipid-regulating, anti-obesity drugs and food/dietary supplements. Dr. Dujovne has authored over 200 scientific articles and 16 book chapters. He is the founding member, Board of Directors, Natl. Lipid Assn, member AHA, ASPET and Diabetes. Dr. Dujovne was the Principal Investigator, Phases I-IV Clinical Trials for R & D of all of FDA's approved and/or marketed lipids regulating and anti-obesity drugs from 1970 to 2011. He is or has been a Consultant to FDA,NIH, and Advisory Boards of most of the largest Pharma and Biotech Companies worldwide. Dr. Dujovne was a Founder and Member of the original Board of Directors of the National Lipid Association (NLA) and is a Fellow of the NLA and an Editorial Reviewer of its Journal of Clinical Lipidology. He is a member of the Nutrition and Dietetics Council and of the International Atherosclerosis Society. Dr. Dujovne is Editorial Reviewer of 25 National and International Scientific Journals. (This is me - Update Profile)

Employment History

2008 - Unspecified

Affiliate Professor of Medicine, OREGON HEALTH & SCIENCE UNIVERSITY - CC

1970 - 1998

Professor of Medicine & Pharmacology, UNIVERSITY OF KANSAS